The effect of insulin on the heart: Part 1: Effects on metabolism and function

Netherlands Heart Journal

Volumn 18, Issue 4, 2010, Pages 197-201

  Klein, L J ^a   Visser, F C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heart; Heart failure; Insulin; Metabolism; Ventricular function

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; INSULIN;

CARBOHYDRATE METABOLISM; CARDIOVASCULAR EFFECT; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HUMAN; INSULIN LIKE ACTIVITY; LOW DRUG DOSE; MORTALITY; NONHUMAN; OXYGEN CONSUMPTION; REVIEW; RISK REDUCTION; SYSTEMIC THERAPY;

EID: 77951951113     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03091761     Document Type: Review

References (46)

1. Visscher MB, Müller EA. The influence of insulin upon the mammalian heart. J Physiol. 1926;62:341-8
2. Rogers WJ, Stanley AW Jr, Breinig JB, Prather JW, McDaniel HG, Moraski RE, et al. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 1976;92:441-54
3. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-23
4. Haneda T, Ganz W, Burnam MH, Katz J. Metabolic effects of glucose-insulin-potassium in the ischemic myocardium. Jpn Heart J. 1978;19:376-82
5. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol. 2000;278:H595-603.
6. Heng MK, Norris RM, Peter T, Nisbet HD, Singh BN. The effect of glucose-insulin-potassium on experimental myocardial infarction in the dog. Cardiovasc Res. 1978;12:429-35.
7. Cave AC, Ingwall JS, Friedrich J, Liao R, Saupe KW, Apstein CS, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation. 2000;2;101:2090-6
8. Hjermann I. A controlled study of peroral glucose, insulin and potassium treatment in myocardial infarction. Acta Med Scand. 1971;190:213-8
9. Stanley AW, Jr., Moraski RE, Russell RO, Rogers WJ, Mantle JA, Kreisberg RA, et al. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol. 1975;36:929-37.
10. Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Rackley CE. Glucose-insulin-potassium, free fatty acids and acute myo cardial infarction in man. Circulation. 1976;53:I207-9.
11. Rogers WJ, Russell RO, Jr., McDaniel HG, Rackley CE. Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man. Am J Cardiol. 1977;40:421-8
12. McDaniel HG, Papapietro SE, Rogers WJ, Mantle JA, Smith LR, Russell RO Jr, et al. Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction. Am Heart J. 1981;102:10-5
13. Ferrannini E, Santoro D, Bonadonna R, Natali A, Parodi O, Camici PG. Metabolic and hemodynamic effects of insulin on human hearts. Am J Physiol. 1993;264:E308-15
14. Szabo Z, Arnqvist H, Hakanson E, Jorfeldt L, Svedjeholm R. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. Clin Sci (Lond). 2001;101:37-43
15. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000;278:H1345-51
16. 11C-acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med. 2001;28:651-68
17. Lucchesi BR, Medina M, Kniffen FJ. The positive inotropic action of insulin in the canine heart. Eur J Pharmacol. 1972;18:107-15
18. Ahmed SS, Lee CH, Oldewurtel HA, Regan TJ. Sustained effect of glucose-insulin-potassium on myocardial performance during regional ischemia. Role of free fatty acid and osmolality. J Clin Invest. 1978;61:1123-35
19. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H et al. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest. 1982;69:1321-36
20. Lee JC, Downing SE. Effects of insulin on cardiac muscle contraction and responsiveness to norepinephrine. Am J Physiol. 1976;230:1360-5
21. Downing SE, Lee JC. Myocardial and coronary vascular responses to insulin in the diabetic lamb. Am J Physiol. 1979;237:H514-9
22. Schmidt HD, Koch M. Influence of perfusate calcium concentration on the inotropic insulin effect in isolated guinea pig and rat hearts. Basic Res Cardiol. 2002;97:305-11.
23. Ramanathan T, Shirota K, Morita S, Nishimura T, Huang Y, Hunyor SN. Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes. Ann Thorac Surg. 2002;73:582-7
24. Meijler FL, Offerijns FG, Willebrands AG, Groen J. Contractiemechanisme en elektrolythuishouding van het geisoleerde, overlevende rattehart, mede in verband met de werking van insuline [Contraction mechanism and electrolyte balance of isolated surviving rat's heart, with reference to an insulin effect]. Ned Tijdschr Geneeskd. 1959;103:1479-86
25. Markovitz LJ, Hasin Y, Freund HR. The effect of insulin and glucagon on systolic properties of the normal and septic isolated rat heart. Basic Res Cardiol. 1985;80:377-83
26. Airaksinen J, Lahtela JT, Ikaheimo MJ, Sotaniemi EA, Takkunen JT. Intravenous insulin has no effect on myocardial contractility or heart rate in healthy subjects. Diabetologia. 1985;28:64952
27. Regan TJ, Frank MJ, Lehan PH, Hellems HK. Relationship of insulin and strophanthidin to myocardial metabolism and function. Am J Physiol. 1963;205:790-4
28. Khoury VK, Haluska B, Prins J, Marwick TH. Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction. Heart. 2003;89:61-5
29. Klein LJ, van Campen LC, Sieswerda GT, Kamp O, Visser CA, Visser FC. Glucose-insulin-potassium echocardiography detects improved segmental myocardial function and viable tissue shortly after acute myocardial infarction. J Am Soc Echocardiogr. 2006;19:763-71
30. Yetkin E, Senen K, Ileri M, Atak R, Tandogan I, Yetkin O, et al. Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coron Artery Dis. 2002;13:145-9.
31. Yetkin E, Senen K, Ileri M, Atak R, Battaoglu B, Yetkin O, et al. Identification of viable myocardium in patients with chronic coronary artery disease and myocardial dysfunction: comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion. Angiology. 2002;53:671-6
32. Cottin Y, Lhuillier I, Gilson L, Zeller M, Bonnet C, Toulouse C, et al. Glucose insulin potassium infusion improves systolic function in patients with chronic ischemic cardiomyopathy. Eur J Heart Fail. 2002;4:181-4
33. Marano L, Bestetti A, Lomuscio A, Tagliabue L, Castini D, Tarricone D, et al. Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol. 2000;55:9-15
34. Sasso FC, Carbonara O, Cozzolino D, Rambaldi P, Mansi L, Torella D, et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol. 2000;36:21926
35. Alan S, Ulgen M, Dedeoglu I, Kaya H, Toprak N. Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischemic cardiomyopathy. Swiss Med Wkly. 2003 26;133:419-22
36. Hiesmayr M, Haider WJ, Grubhofer G, Heilinger D, Keznickl FP, Mares P, et al. Effects of dobutamine versus insulin on cardiac performance, myocardial oxygen demand, and total body metabolism after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 1995;9:653-8
37. Coleman GM, Gradinac S, Taegtmeyer H, Sweeney M, Frazier OH. Efficacy of metabolic support with glucose-insulin-potassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation. 1989;80:I91-6
38. Lazar HL, Philippides G, Fitzgerald C, Lancaster D, Shemin RJ, Apstein C. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1997;113:354-60
39. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional reco very of the heart. Am J Cardiol. 1997;80:3A-10A.
40. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-50
41. Bruemmer-Smith S, Avidan MS, Harris B, Sudan S, Sherwood R, Desai JB, et al. Glucose, insulin and potassium for heart pro tection during cardiac surgery. Br J Anaesth. 2002;88:489-95.
42. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE Jr, Kirklin JK, Stanley AW Jr. Glucose-insulin-potassium infusion for myocar dial protection during offpump coronary artery surgery. Ann Thorac Surg. 2002;73:1246-51
43. McNulty PH, Pfau S, Deckelbaum LI. Effect of plasma insulin level on myocardial blood flow and its mechanism of action. Am J Cardiol. 2000;85:161-5
44. McDaniel HG, Rogers WJ, Russell RO Jr, Rackley CE. Impro ved myocardial contractility with glucose-insulin-potassium in fusion during pacing in coronary artery disease. Am J Cardiol. 1985;55:932-6.
45. Iozzo P, Chareonthaitawee P, Di TM, Betteridge DJ, Ferrannini E, Camici PG. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans. Am J Physiol Endocrinol Metab. 2002;282:E116371
46. Sundell J, Nuutila P, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, et al. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes. 2002;51:1125-30.